Australian Health Performance Framework: PI 3.1.2–Incidence of selected cancers, 2019
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
|---|---|
| Indicator type: | Indicator |
| Short name: | AHPF PI 3.1.2–Incidence of selected cancers, 2019 |
| METEOR identifier: | 715297 |
| Registration status: | Health, Superseded 13/10/2021 |
| Description: | Incidence of selected cancers of public health importance. |
| Indicator set: | Australian Health Performance Framework, 2019 Health, Superseded 13/10/2021 Australian Health Performance Framework, 2019 Health, Superseded 13/10/2021 |
Collection and usage attributes | |
| Computation description: | Rates directly age-standardised to the 2001 Australian Standard Population. Analyses by state and territory, remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) are based on the state or territory and Statistical Area Level 2 (SA2) of the person at the time of their diagnosis. Rates that are considered unstable and should be interpreted with caution will be noted. Rates that are considered very unstable will not be published. Presented as:
|
|---|---|
| Computation: | 100,000 × (Numerator ÷ Denominator) Calculated separately for each type of cancer. |
| Numerator: | For melanoma, bowel and lung cancer: Number of new cases in the reported year. For cervical and breast cancer in females: Number of new cases in females in the reported year. |
| Numerator data elements: | |
| Denominator: | For melanoma, bowel and lung cancer: Total population. For cervical and breast cancer in females: Total female population. |
| Denominator data elements: | |
| Disaggregation: | 2015—State and territory (excluding New South Wales), by:
2015—Nationally (excluding New South Wales), by:
2010–2014—Primary Health Network (PHN), by:
Data are provided as counts of new cases and age-standardised rates. Data for 2015 excludes New South Wales. Cancer types in these disaggregations comprise: bowel cancer (ICD-10 2016 version codes C18–C20), lung cancer (C33–C34), melanoma of the skin (C43), female breast cancer (C50) and cervical cancer (C53). Some disaggregation may result in numbers too small for publication. Disaggregation by remoteness area is subject to availability of suitable population data. |
| Disaggregation data elements: | |
| Comments: | Most recent data available for 2019 Australian Health Performance Framework reporting: 2015 (state/territory and national, excluding NSW); 2010–2014 (PHN). NSW data for 2015 are not available. |
Representational attributes | |
| Representation class: | Rate |
| Data type: | Real |
| Unit of measure: | Episode |
| Format: | N[NN].N |
Indicator conceptual framework | |
| Framework and dimensions: | 1. Health conditions |
Data source attributes | |
| Data sources: | |
Accountability attributes | |
| Reporting requirements: | Australian Health Performance Framework |
| Organisation responsible for providing data: | Australian Institute of Health and Welfare |
| Accountability: | Australian Institute of Health and Welfare |
Source and reference attributes | |
| Submitting organisation: | Australian Institute of Health and Welfare |
Relational attributes | |
| Related metadata references: | Has been superseded by Australian Health Performance Framework: PI 3.1.2–Incidence of selected cancers, 2020 Health, Standard 13/10/2021 See also Australian Health Performance Framework: PI 2.1.5–Survival of people diagnosed with cancer, 2019 Health, Superseded 01/12/2020 See also National Healthcare Agreement: PI 02–Incidence of selected cancers, 2020 Health, Standard 13/03/2020 See also National Healthcare Agreement: PI 02–Incidence of selected cancers, 2021 Health, Standard 16/09/2020 |